Related Experiment Video
Updated: May 25, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs in Hepatobiliary and Pancreatic Cancers
Yoshimasa Saito1, Hidekazu Suzuki, Misa Matsuura
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University Tokyo, Japan.
Abstract:
MicroRNAs (miRNAs) are small non-coding RNAs that function as endogenous silencers of numerous target genes. Hundreds of miRNAs have been identified in the human genome. miRNAs are expressed in a tissue-specific manner and play important roles in cell proliferation, apoptosis, and differentiation. Aberrant expression of miRNAs may also contribute to the development and progression of human hepatobiliary and pancreatic cancers. Recent studies have shown that some miRNAs play roles as tumor suppressors or oncogenes in hepatobiliary and pancreatic cancers. miR-122, let-7 family, and miR-101 are down-regulated in hepatocellular carcinoma (HCC), suggesting that it is a potential tumor suppressor of HCC. miR-221 and miR-222 are up-regulated in HCC and may act as oncogenic miRNAs in hepatocarcinogenesis. miRNA expression profiling may be a powerful clinical tool for diagnosis and regulation of miRNA expression could be a novel therapeutic strategy for hepatobiliary and pancreatic cancers. In this review, we summarize current knowledge about the roles of important tumor suppressor microRNAs and oncogenic microRNAs in hepatobiliary and pancreatic cancers.
Insights
MicroRNAs (miRNAs) are small non-coding RNAs crucial for gene silencing. Aberrant miRNA expression is linked to hepatobiliary and pancreatic cancers, with some acting as tumor suppressors or oncogenes.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- They are tissue-specific and vital for cellular processes like proliferation and differentiation.
- Dysregulated miRNA expression is implicated in hepatobiliary and pancreatic cancers.
Purpose of the Study:
- To review the roles of tumor suppressor and oncogenic microRNAs in hepatobiliary and pancreatic cancers.
- To highlight the diagnostic and therapeutic potential of miRNA expression profiling.
Main Methods:
- Literature review of current research on miRNA roles in hepatobiliary and pancreatic cancers.
- Analysis of specific miRNA expression patterns (up-regulation/down-regulation) in cancer.
Main Results:
- Certain miRNAs (e.g., miR-122, let-7, miR-101) act as tumor suppressors in hepatocellular carcinoma (HCC).
- Other miRNAs (e.g., miR-221, miR-222) function as oncogenes in hepatocarcinogenesis.
- miRNA expression profiling shows promise for cancer diagnosis.
Conclusions:
- miRNAs play dual roles as tumor suppressors and oncogenes in hepatobiliary and pancreatic cancers.
- miRNA expression analysis is a valuable tool for cancer diagnosis.
- Modulating miRNA expression offers a potential novel therapeutic strategy for these cancers.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

